WeVote
Log In

Bill

Bill

HB 1255

TO AMEND THE COVERAGE OF A CONTINUOUS GLUCOSE MONITOR IN THE ARKANSAS MEDICAID PROGRAM.

2025 Regular Session Introduced by Breanne Davis and 1 co-sponsor

Arkansas expands Medicaid coverage for continuous glucose monitors to improve diabetes management access for low-income residents.

Notification that HB1255 is now Act 857
0
WeVote Research Nonpartisan
Bill Summary · HB 1255

Legislative bill overview

HB 1255 amends Arkansas's Medicaid program to expand coverage of continuous glucose monitors (CGMs). The bill modifies existing coverage policies to make CGMs more accessible to eligible Medicaid beneficiaries who manage diabetes. It has been signed into law as Act 857.

Why is this important

Continuous glucose monitors help people with diabetes track blood sugar levels in real-time, potentially reducing dangerous complications and hospitalizations. Expanding Medicaid coverage addresses a significant access barrier for low-income Arkansans with diabetes, who often cannot afford these devices ($2,000-4,000+ annually out-of-pocket). This policy change could improve health outcomes while potentially reducing long-term Medicaid costs from preventable diabetes complications.

Potential points of contention

  • Budget impact: Expanded CGM coverage increases Medicaid expenditures, which may compete with funding for other healthcare services or require tax adjustments
  • Eligibility criteria: Details on which Medicaid beneficiaries qualify (age restrictions, diabetes type, prior authorization requirements) affect how many people actually benefit and at what cost
  • Device manufacturer relationships: Coverage decisions may favor certain CGM brands over others, raising questions about fair market competition and whether beneficiaries can access their preferred devices

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.